ADVANCED ONCOTHERAPY Plc
("Advanced Oncotherapy" or "the Company")
Advanced Oncotherapy was informed on 18 July 2013 that, as of 15 July 2013, Mr Michael Horgan was beneficially interested in a total of 36,666,667 ordinary shares in the Company which represents approximately 9.14% of the issued share capital of the Company.
For further information, please visit www.advancedoncotherapy.com or contact:
Michael Sinclair, Chief Executive |
Sandy Jamieson |
Jon Levinson/Lucy Williams |
Simon Hudson |
Advanced Oncotherapy Plc |
Libertas Capital Corporate Finance Ltd |
Peterhouse Corporate Finance |
Tavistock Communications |
|
(NOMAD & Joint Broker) |
(Joint Broker) |
(Financial PR & IR) |
+44 20 3617 8739 |
+44 20 3697 9495 |
+44 20 7469 0930 |
+44 20 7920 3150 |